Connection

LI-YUAN YU-LEE to Humans

This is a "connection" page, showing publications LI-YUAN YU-LEE has written about Humans.
Connection Strength

0.295
  1. Bone secreted factors induce cellular quiescence in prostate cancer cells. Sci Rep. 2019 12 09; 9(1):18635.
    View in: PubMed
    Score: 0.017
  2. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGF?RIII-p38MAPK-pS249/T252RB Pathway. Cancer Res. 2018 06 01; 78(11):2911-2924.
    View in: PubMed
    Score: 0.015
  3. Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis. PLoS One. 2016; 11(4):e0153455.
    View in: PubMed
    Score: 0.013
  4. NudC deacetylation regulates mitotic progression. PLoS One. 2013; 8(9):e73841.
    View in: PubMed
    Score: 0.011
  5. Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene. 2013 Jun 13; 32(24):2973-83.
    View in: PubMed
    Score: 0.010
  6. Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells. FASEB J. 2012 Oct; 26(10):4057-67.
    View in: PubMed
    Score: 0.010
  7. Identifying acetylated proteins in mitosis. Methods Mol Biol. 2012; 909:181-204.
    View in: PubMed
    Score: 0.010
  8. Acetylation of RNA processing proteins and cell cycle proteins in mitosis. J Proteome Res. 2010 Sep 03; 9(9):4554-64.
    View in: PubMed
    Score: 0.009
  9. PICH and cotargeted Plk1 coordinately maintain prometaphase chromosome arm architecture. Mol Biol Cell. 2010 Apr 01; 21(7):1188-99.
    View in: PubMed
    Score: 0.008
  10. Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore-microtubule attachment. Proc Natl Acad Sci U S A. 2008 Mar 18; 105(11):4179-84.
    View in: PubMed
    Score: 0.007
  11. 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway. Cancer Res. 2007 Nov 15; 67(22):11045-53.
    View in: PubMed
    Score: 0.007
  12. NudC is required for Plk1 targeting to the kinetochore and chromosome congression. Curr Biol. 2006 Jul 25; 16(14):1414-21.
    View in: PubMed
    Score: 0.007
  13. Inhibition of prostate tumor growth by overexpression of NudC, a microtubule motor-associated protein. Oncogene. 2004 Apr 01; 23(14):2499-506.
    View in: PubMed
    Score: 0.006
  14. Role for NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis. J Cell Sci. 2003 May 15; 116(Pt 10):1991-2003.
    View in: PubMed
    Score: 0.005
  15. Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition. Cancer Res. 2022 09 02; 82(17):3158-3171.
    View in: PubMed
    Score: 0.005
  16. Prolactin modulation of immune and inflammatory responses. Recent Prog Horm Res. 2002; 57:435-55.
    View in: PubMed
    Score: 0.005
  17. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition. Oncogene. 2022 Feb; 41(6):757-769.
    View in: PubMed
    Score: 0.005
  18. Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone. Oncogene. 2021 Jul; 40(27):4592-4603.
    View in: PubMed
    Score: 0.005
  19. Stimulation of interferon regulatory factor-1 by prolactin. Lupus. 2001; 10(10):691-9.
    View in: PubMed
    Score: 0.004
  20. Association of 2',5'-oligoadenylate synthetase with the prolactin (PRL) receptor: alteration in PRL-inducible stat1 (signal transducer and activator of transcription 1) signaling to the IRF-1 (interferon-regulatory factor 1) promoter. Mol Endocrinol. 2000 Feb; 14(2):295-306.
    View in: PubMed
    Score: 0.004
  21. Stat5b inhibits NFkappaB-mediated signaling. Mol Endocrinol. 2000 Jan; 14(1):114-23.
    View in: PubMed
    Score: 0.004
  22. Osteoblastic Factors in Prostate Cancer Bone Metastasis. Curr Osteoporos Rep. 2018 12; 16(6):642-647.
    View in: PubMed
    Score: 0.004
  23. Prolactin and growth hormone signal transduction in lymphohaemopoietic cells. Cell Mol Life Sci. 1998 Oct; 54(10):1067-75.
    View in: PubMed
    Score: 0.004
  24. Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II. Cancer Res. 2018 05 15; 78(10):2490-2502.
    View in: PubMed
    Score: 0.004
  25. Lactogenic hormone signal transduction. Biol Reprod. 1998 Feb; 58(2):295-301.
    View in: PubMed
    Score: 0.004
  26. Expression of RNUDC, a potential nuclear movement protein, in mammalian cells: localization to the Golgi apparatus. Exp Cell Res. 1998 Jan 10; 238(1):23-32.
    View in: PubMed
    Score: 0.004
  27. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation. Neoplasia. 2018 01; 20(1):32-43.
    View in: PubMed
    Score: 0.004
  28. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters. J Biol Chem. 1997 Oct 24; 272(43):26841-9.
    View in: PubMed
    Score: 0.004
  29. Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer Cells. J Proteome Res. 2017 08 04; 16(8):2709-2728.
    View in: PubMed
    Score: 0.004
  30. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Dev Cell. 2017 06 05; 41(5):467-480.e3.
    View in: PubMed
    Score: 0.003
  31. Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med. 1997 May; 215(1):35-52.
    View in: PubMed
    Score: 0.003
  32. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway. Oncotarget. 2017 Feb 07; 8(6):10145-10160.
    View in: PubMed
    Score: 0.003
  33. Therapeutic relevance of the protein phosphatase 2A in cancer. Oncotarget. 2016 Sep 20; 7(38):61544-61561.
    View in: PubMed
    Score: 0.003
  34. Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Res. 2015 Nov 15; 75(22):4949-59.
    View in: PubMed
    Score: 0.003
  35. Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells. J Cell Sci. 2015 Dec 15; 128(24):4629-41.
    View in: PubMed
    Score: 0.003
  36. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment. Mol Cell Proteomics. 2015 Mar; 14(3):471-83.
    View in: PubMed
    Score: 0.003
  37. Angiomotin is a novel component of cadherin-11/?-catenin/p120 complex and is critical for cadherin-11-mediated cell migration. FASEB J. 2015 Mar; 29(3):1080-91.
    View in: PubMed
    Score: 0.003
  38. The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor. Cell Rep. 2014 Nov 20; 9(4):1318-32.
    View in: PubMed
    Score: 0.003
  39. Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation. J Biol Chem. 1994 Oct 21; 269(42):26076-82.
    View in: PubMed
    Score: 0.003
  40. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocr Rev. 1994 Oct; 15(5):627-49.
    View in: PubMed
    Score: 0.003
  41. RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival. Mol Cancer Res. 2015 Feb; 13(2):348-57.
    View in: PubMed
    Score: 0.003
  42. Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene. Mol Endocrinol. 1994 Mar; 8(3):345-55.
    View in: PubMed
    Score: 0.003
  43. The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage. J Immunol. 2014 Jan 01; 192(1):178-88.
    View in: PubMed
    Score: 0.003
  44. The proline-rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor superfamily. Lymphokine Cytokine Res. 1993 Oct; 12(5):309-12.
    View in: PubMed
    Score: 0.003
  45. Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis. Mol Cancer Res. 2013 Nov; 11(11):1401-11.
    View in: PubMed
    Score: 0.003
  46. RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B. Oncogene. 2014 May 01; 33(18):2385-94.
    View in: PubMed
    Score: 0.003
  47. Targeting constitutively activated ?1 integrins inhibits prostate cancer metastasis. Mol Cancer Res. 2013 Apr; 11(4):405-17.
    View in: PubMed
    Score: 0.003
  48. Prolactin gene expression in human thymocytes. Mol Cell Endocrinol. 1992 Sep; 87(1-3):R19-23.
    View in: PubMed
    Score: 0.003
  49. Aberrant expression of katanin p60 in prostate cancer bone metastasis. Prostate. 2012 Feb; 72(3):291-300.
    View in: PubMed
    Score: 0.002
  50. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res. 2011 Aug 01; 71(15):5194-203.
    View in: PubMed
    Score: 0.002
  51. Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res. 2010 Nov 01; 70(21):8812-21.
    View in: PubMed
    Score: 0.002
  52. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol. 1990 Jun; 10(6):3087-94.
    View in: PubMed
    Score: 0.002
  53. Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res. 2010 Jun 01; 70(11):4580-9.
    View in: PubMed
    Score: 0.002
  54. Androgen depletion up-regulates cadherin-11 expression in prostate cancer. J Pathol. 2010 May; 221(1):68-76.
    View in: PubMed
    Score: 0.002
  55. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. Oncogene. 2010 Jun 03; 29(22):3196-207.
    View in: PubMed
    Score: 0.002
  56. Prolactin-mediated regulation of gene transcription in lymphocytes. Ann N Y Acad Sci. 1990; 594:146-55.
    View in: PubMed
    Score: 0.002
  57. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res. 2008 Aug; 6(8):1259-67.
    View in: PubMed
    Score: 0.002
  58. Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res. 2008 Jul 01; 68(13):5460-8.
    View in: PubMed
    Score: 0.002
  59. Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Clin Cancer Res. 2008 Jun 15; 14(12):3729-36.
    View in: PubMed
    Score: 0.002
  60. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008 Sep 04; 27(39):5195-203.
    View in: PubMed
    Score: 0.002
  61. A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res. 2007 Jul 15; 67(14):6544-8.
    View in: PubMed
    Score: 0.002
  62. Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. Mol Cancer Res. 2007 Jul; 5(7):675-84.
    View in: PubMed
    Score: 0.002
  63. The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev. 2006 Dec; 25(4):601-9.
    View in: PubMed
    Score: 0.002
  64. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. J Pathol. 2004 Jun; 203(2):688-95.
    View in: PubMed
    Score: 0.001
  65. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004 May 01; 64(9):3072-8.
    View in: PubMed
    Score: 0.001
  66. A role for Plk1 phosphorylation of NudC in cytokinesis. Dev Cell. 2003 Jul; 5(1):127-38.
    View in: PubMed
    Score: 0.001
  67. Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells. Protein Expr Purif. 2003 Apr; 28(2):252-8.
    View in: PubMed
    Score: 0.001
  68. Antitumor activity of the 16-kDa prolactin fragment in prostate cancer. Cancer Res. 2003 Jan 15; 63(2):386-93.
    View in: PubMed
    Score: 0.001
  69. Roles of Stat1, Stat2, and interferon regulatory factor-9 (IRF-9) in interferon tau regulation of IRF-1. Biol Reprod. 2002 Feb; 66(2):393-400.
    View in: PubMed
    Score: 0.001
  70. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation. J Immunol. 1999 Nov 01; 163(9):4663-72.
    View in: PubMed
    Score: 0.001
  71. Localization of interferon regulatory factor-1 (IRF-1) in nonpregnant human endometrium: expression of IRF-1 is up-regulated by prolactin during the secretory phase of the menstrual cycle. J Clin Endocrinol Metab. 1999 Nov; 84(11):4260-5.
    View in: PubMed
    Score: 0.001
  72. A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of Stat5B. J Biol Chem. 1999 Feb 19; 274(8):5138-45.
    View in: PubMed
    Score: 0.001
  73. The proline-rich motif is necessary but not sufficient for prolactin receptor signal transduction. Ann N Y Acad Sci. 1995 Sep 07; 766:282-4.
    View in: PubMed
    Score: 0.001
  74. Structure and specificities of anti-ganglioside autoantibodies associated with motor neuropathies. J Immunol. 1992 Oct 01; 149(7):2518-29.
    View in: PubMed
    Score: 0.001
  75. Polymorphism of human immunoglobulin VH4 germ-line genes. Eur J Immunol. 1992 Apr; 22(4):1075-82.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.